MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to stockholders
-$7,682K
(-98.81%↓ Y/Y)
Net loss
attributable to...
-$69K
Sleep Testing
Services
$2,296K
(610.84%↑ Y/Y)
Treatment Centers
$892K
Sponsorship Seminar Other
$205K
(-37.50%↓ Y/Y)
Billing Intelligence
Services
$145K
(-19.89%↓ Y/Y)
Myofunctional Therapy
Services
$125K
(-15.54%↓ Y/Y)
VIP
$37K
(-83.41%↓ Y/Y)
Revenue From Contract
With Customer...
$1,440K
(-20.57%↓ Y/Y)
Net loss
-$7,751K
(-100.60%↓ Y/Y)
Service
$3,701K
(207.65%↑ Y/Y)
Product
$1,440K
(-20.57%↓ Y/Y)
Loss before income
taxes
-$7,751K
(-100.60%↓ Y/Y)
Other income
$31K
(-46.55%↓ Y/Y)
Total revenue
$5,141K
(70.46%↑ Y/Y)
Operating loss
-$6,615K
(-68.84%↓ Y/Y)
Other expense
-$1,167K
(-29075.00%↓ Y/Y)
Gross profit
$3,059K
(102.72%↑ Y/Y)
Cost of sales
(exclusive of depreciation...
$2,082K
(38.16%↑ Y/Y)
Total operating
expenses
$9,674K
(78.26%↑ Y/Y)
General and
administrative
$8,971K
(83.38%↑ Y/Y)
Depreciation and
amortization
$454K
(156.50%↑ Y/Y)
Sales and marketing
$249K
(-30.45%↓ Y/Y)
Back
Back
Income Statement
Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS)
source: myfinsight.com